R (U.S. Trademark Serial Number 79195516) is a United States trademark of RIVOPHARM S.A.. The goods and services include: The mark consists of a stylized letter “R” with a beaker design forming the left side of the letter “R”. Pharmaceutical preparations, both prescription and over-the-counter, namely, pharmaceutical preparations for peptic ulcer and gastrooesophageal reflux disease (GORD), propulsives, intestinal anti-infectives, intestinal anti-inflammatory agents, oral pharmaceutical preparations for lowering blood glucose, Vitamin A and D, mixed vitamin preparations consisting of vitamins A and D, vitamin and mineral preparations for medical use, vitamin C in the nature of ascorbic acid mixed vitamin preparations consisting partially of Vitamin C, calcium supplements, mineral supplements, anti-thrombotic agents, intravenous solutions, cardiac glycosides, class I and class III anti-arrhythmics, pharmaceutical preparations for cardiac stimulation excluding cardiac glycosides, Vasodilators used in the treatment of cardiac diseases, anti-adrenergic agents, pharmaceutical preparations for acting on arteriolar smooth muscle, Beta blocking agents, Selective calcium channel blockers, pharmaceutical preparations in the nature of Angiotensin Converting Enzyme inhibitors, pharmaceutical preparations in the nature of Angiotensin Converting Enzyme inhibitors combined with other pharmaceutical preparations, anti-fungals for systemic use, anti-infectives and antiseptics, excluding those combined with corticosteroids, oxytocics, plain corticosteroids for systemic use, thyroid preparations, anti-thyroid preparations, tetracyclines preparations, macrolides, lincosamides and streptogramins, aminoglycoside antibacterials, quinolone antibacterials, antimycotics for systemic use, direct acting antivirals, immune sera, bacterial vaccines, alkylating agents, anti-metabolites, plant alkaloids, cytotoxic antibiotics, hormone antagonists and related agents, namely, anti-estrogens, anti-androgens and enzyme inhibitors, immunosuppressive agents, antiinflammatory and antirheumatic preparations, non-steroids in the nature of butylpyrazolidines, acetic acid derivatives, oxicams, propionic acid derivatives, fenamates, Coxibs, muscle relaxants, peripherally acting agents in the nature of curare alkaloids and choline derivatives, antigout preparations, analgesics and antipyretics preparations, anti-migraine preparations, anti-epileptic preparations, anti-cholinergic agents, dopaminergic agents, anti-psychotics, anxiolytics, hypnotics and sedatives, antidepressants, parasympathomimetics, agents for use against amoebiasis and other protozoal diseases, anti-malarial preparation, adrenergics, inhalant anesthetics, adrenergics for systemic use, antihistamines for systemic use, diuretic agents Color is not claimed as a feature of the mark.. The correspondent is Jeffrey B. Sladkus of The Sladkus Law Group.

This trademark was filed on October 17, 2016 as United States Trademark Application Serial Number 79195516. The trademark application was registered on July 04, 2017 as U.S. Trademark Registration 5234474.

Trademark PTO Status History

July 04, 2022 – COURTESY REMINDER – SEC. 71 (6-YR) E-MAILED

November 03, 2017 – FINAL DECISION TRANSACTION PROCESSED BY IB

October 13, 2017 – NOTIFICATION PROCESSED BY IB

October 05, 2017 – FINAL DISPOSITION NOTICE SENT TO IB

October 05, 2017 – FINAL DISPOSITION PROCESSED

October 04, 2017 – FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

July 04, 2017 – REGISTERED-PRINCIPAL REGISTER

April 18, 2017 – OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

View full trademark status information at USPTO

Ownership History

RIVOPHARM S.A.

RIVOPHARM S.A.

RIVOPHARM S.A.

View documents on file at USPTO

File a Trademark or Get Help With Trademark Law

Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.